Aeromonas hydrophila sepsis in a patient with acute myeloid leukemia on azacitidine chemo therapies

Aeromonas hydrophila is an optional anaerobic oxidase + opportunistic Gram-negative bacillus in subjects during immunosuppressive disease or therapy. We report a case of A. hydrophila sepsis in a 73-year-old patient with acute myeloid leukemia who has been undergoing chemotherapy for 7 months after consulting for a fever that had been evolving for a week. On admission, the physical examination showed a temperature of 39.2°C, a blood pressure of 100/60 mmHg and a heart rate of 135 beats/min. Blood cultures were positive for A. hydrophila of wild-type phenotype, as it was sensitive to piperacillin, ceftazidime, imipenem, amikacin, gentamicin, doxycycline, trimethoprim-sulfamethoxazole and ciprofloxacin. The patient was successfully treated with imipenem and then cefixime orally. Keywords: Sepsis, Aeromonas hydrophila, chronic myeloid leukemia, azacitidine.